Although traditionally considered a tumor suppressor [20,55,56], recent studies suggest a pro-oncogenic role for IRF8, particularly in acute myeloid leukemia (AML), where elevated IRF8 expression correlates with poor prognosis [57,58,59]. Here, IRF8 is linked to acute myeloid leukemia.